Investigational combination therapy CagriSema demonstrated significant weight reduction and noninferior HbA1c lowering in phase 3 clinical trials.
HealthDay News — High-frequency spinal cord stimulation significantly reduces pain and improves sensory function in people with painful diabetic neuropathy, according to a study published online ...
HealthDay News — For adults with type 2 diabetes receiving sodium-glucose cotransporter-2 (SGLT2) inhibitors, risk factors for ketoacidosis include high hemoglobin A1c, previous ketoacidosis, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results